Literature DB >> 25129403

Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Wenyu Jiang1, Jiewen Su, Xiaofei Zhang, Xiuqin Cheng, Jun Zhou, Ruihua Shi, Hongjie Zhang.   

Abstract

OBJECTIVE: Interleukin-17(IL-17)-producing T helper(Th)17 cells are considered as a new subset of cells critical to the development of inflammatory bowel disease (IBD). We aimed to investigate the distribution of Th17 cells, the expressions of Th17-related cytokines (IL-17, IL-21 and IL-22) and their association with disease activity in IBD patients.
METHODS: We collected intestinal tissue biopsies from 40 patients with active ulcerative colitis (UC), 20 patients with active Crohn's disease (CD) and 20 healthy controls. The distribution of Th17 cells and expressions of Th17-related cytokines in colonic tissues were evaluated by a standard immunohistochemical procedure. Serum IL-17, IL-21 and IL-22 levels were determined by ELISA. Pearson's and Spearman's correlation analyses were performed to analyze the correlation between the number of Th17 cells, the expressions of Th17-related cytokines and disease activity index, endoscopic and histological grading, and CRP and PLT levels, respectively.
RESULTS: Compared with healthy controls, the number of Th17 cells and the expressions of IL-17, IL-21 and IL-22 were significantly increased in active IBD patients (P < 0.05). In addition, Pearson's and Spearman's correlation analyses showed that the number of Th17 cells and the expressions of Th17-related cytokines were correlated with disease activity index, endoscopic and histological grading, CRP and PLT levels (P < 0.05).
CONCLUSIONS: Th17 cells and Th17-related cytokines (IL-17, IL-21 and IL-22) were increased in the intestinal mucosa in active IBD patients and may play an important role in disease activity and mucosal damage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25129403     DOI: 10.1007/s00011-014-0768-7

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  26 in total

1.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.

Authors:  Charles N Bernstein; Michael Fried; J H Krabshuis; Henry Cohen; R Eliakim; Suleiman Fedail; Richard Gearry; K L Goh; Saheed Hamid; Aamir Ghafor Khan; A W LeMair; Qin Ouyang; J F Rey; Ajit Sood; Flavio Steinwurz; Ole O Thomsen; Alan Thomson; Gillian Watermeyer
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

Review 2.  Interactions between the host innate immune system and microbes in inflammatory bowel disease.

Authors:  Clara Abraham; Ruslan Medzhitov
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 3.  T(H)17 cytokines in autoimmune neuro-inflammation.

Authors:  Burkhard Becher; Benjamin M Segal
Journal:  Curr Opin Immunol       Date:  2011-09-09       Impact factor: 7.486

Review 4.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

Review 5.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 6.  IL-21 comes of age as a regulator of effector T cells in the gut.

Authors:  M C Fantini; G Monteleone; T T MacDonald
Journal:  Mucosal Immunol       Date:  2008-01-23       Impact factor: 7.313

7.  IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response.

Authors:  Mari Strengell; Timo Sareneva; Don Foster; Ilkka Julkunen; Sampsa Matikainen
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  Aberrant prothymosin-alpha expression in human bladder cancer.

Authors:  Yuh-Shyan Tsai; Yeong-Chin Jou; Gia-Fong Lee; Yeong-Chang Chen; Ai-Li Shiau; Hsin-Tzu Tsai; Chao-Liang Wu; Tzong-Shin Tzai
Journal:  Urology       Date:  2008-08-09       Impact factor: 2.649

Review 9.  Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.

Authors:  Meredith M Curtis; Sing Sing Way
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.

Authors:  Veera Hölttä; Paula Klemetti; Harri M Salo; Antti Koivusalo; Mikko Pakarinen; Mia Westerholm-Ormio; Kaija-Leena Kolho; Outi Vaarala
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

View more
  62 in total

1.  Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort.

Authors:  N Senhaji; A Serrano; W Badre; N Serbati; M Karkouri; Y Zaid; S Nadifi; J Martin
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

Review 2.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

3.  Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Leukoc Biol       Date:  2019-03-21       Impact factor: 4.962

4.  Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17.

Authors:  Giulio Kleiner; Valentina Zanin; Lorenzo Monasta; Sergio Crovella; Lorenzo Caruso; Daniela Milani; Annalisa Marcuzzi
Journal:  Exp Ther Med       Date:  2015-03-19       Impact factor: 2.447

5.  Bilirubin suppresses Th17 immunity in colitis by upregulating CD39.

Authors:  Maria Serena Longhi; Marta Vuerich; Alireza Kalbasi; Jessica E Kenison; Ada Yeste; Eva Csizmadia; Byron Vaughn; Linda Feldbrugge; Shuji Mitsuhashi; Barbara Wegiel; Leo Otterbein; Alan Moss; Francisco J Quintana; Simon C Robson
Journal:  JCI Insight       Date:  2017-05-04

Review 6.  Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.

Authors:  Giovanni Latella; Angelo Viscido
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

7.  Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Mohamed F Elshal; Alia M Aldahlawi; Omar I Saadah; J Philip Mccoy
Journal:  Clin Lab       Date:  2016-08-01       Impact factor: 1.138

8.  Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Authors:  Ji Li; Aito Ueno; Marietta Iacucci; Miriam Fort Gasia; Humberto B Jijon; Remo Panaccione; Gilaad G Kaplan; Paul L Beck; Joanne Luider; Herman W Barkema; Jiaming Qian; Xianyong Gui; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

9.  Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.

Authors:  Taejun Yoon; Sung Soo Ahn; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2019-03-12       Impact factor: 2.980

10.  VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis.

Authors:  Xiaolei Wang; Jin Zhao; Li Qin
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.